FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16680011000001109: Vascace 2.5mg tablets (Stephar (U.K.) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Mar 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58663301000001116 Vascace 2.5mg tablets (Stephar (U.K.) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58663401000001112 Vascace 2.5mg tablets (Stephar (U.K.) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Is a Cilazapril 2.5mg tablets false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Is a Cilazapril 2.5mg tablets true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Is a Product containing precisely cilazapril 2.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has active ingredient Cilazapril false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Is a Vascace true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has specific active ingredient Cilazapril monohydrate true Inferred relationship Existential restriction modifier
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Has basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vascace 2.5mg tablets (Stephar (U.K.) Ltd) 28 tablet Has AMP True Vascace 2.5mg tablets (Stephar (U.K.) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start